Sotorasib Plus Panitumumab Provides Effective Targeted Therapy Option in KRAS G12C+ mCRC
Marwan G. Fakih, MD, discusses the FDA approval of sotorasib plus panitumumab in KRAS G12C–mutated metastatic colorectal cancer.
Related Articles
HR-1701 Plus Chemo Reduces Myelosuppression in HER2-Negative Gastric and GEJ Adenocarcinoma
SHR-1701 plus CAPOX chemotherapy elicited fewer chemo delays and dose reductions and improved AE data vs placebo plus CAPOX in HER2-negative gastric/GEJ cancer.
Evorpacept Plus TRP Generates Superior Antitumor Responses, Survival Outcomes in HER2+ Gastric/GEJ Cancer
Evorpacept plus TRP produced superior ORR, DOR, and PFS outcomes vs TRP alone in patients with HER2-positive gastric or gastroesophageal junction cancer.
Dr Lang on Real-World Outcomes With the KEYNOTE-522 Regimen in Early-Stage TNBC
Julie Lang, MD, discusses real-world outcomes of the neoadjuvant KEYNOTE-522 regimen in patients with early-stage triple-negative breast cancer.
Clinical Case Evolution: Disease Progression Patterns After Initial Therapy
Panelists discuss how myelofibrosis can evolve following initial treatment, examining common patterns of disease progression and strategies for adapting therapeutic approaches based on individual patient…
Simplifying clinical use of TCGA molecular subtypes through machine learning models
In this issue of Cancer Cell, Ellrott et al. present machine learning models to classify samples into The Cancer Genome Atlas (TCGA) molecular subtypes using compact…
View From the Other Side of the Stethoscope: On Love &… : Oncology Times
An abstract is unavailable.
Protocol Reduces Side Effects Before Myeloma Transplant : Oncology Times
An abstract is unavailable.
Dr McNall-Knapp on HRQOL Outcomes With Mirdametinib in NF1-PN
Rene Y. McNall-Knapp, MD, discusses HRQOL outcomes from the ReNeu trial investigating mirdametinib in patients with NF1-PN.
2024 Hot Topic in Basic & Translational Science Conference Highlights | IASLC
IASLC presents a one-hour, live session focused on key highlights from the 2024 Hot Topic in Basic & Translational Science Conference. This webinar will…
Welcome! You are invited to join a webinar: SSO CGSO Videoconference: Melanoma. After registering, you will receive a confirmation email about joining the webinar.
SSO sponsors educational videoconferences for CGSO Fellows, Residents, and faculty. This session will discuss the management of melanoma in both the localized and metastatic setting.…
